Vericel

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vericel and other ETFs, options, and stocks.

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. 

CEO
Dominick C. Colangelo
CEODominick C. Colangelo
Employees
398
Employees398
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1989
Founded1989
Employees
398
Employees398

VCEL Key Statistics

Market cap
1.73B
Market cap1.73B
Price-Earnings ratio
102.81
Price-Earnings ratio102.81
Dividend yield
Dividend yield
Average volume
1.02M
Average volume1.02M
High today
$35.10
High today$35.10
Low today
$31.21
Low today$31.21
Open price
$31.82
Open price$31.82
Volume
1.69M
Volume1.69M
52 Week high
$45.97
52 Week high$45.97
52 Week low
$28.95
52 Week low$28.95

Stock Snapshot

As of today, Vericel(VCEL) shares are valued at $34.33. The company's market cap stands at 1.73B, with a P/E ratio of 102.81.

As of 2026-04-03, Vericel(VCEL) stock has fluctuated between $31.21 and $35.10. The current price stands at $34.33, placing the stock +10.0% above today's low and -2.2% off the high.

The Vericel(VCEL)'s current trading volume is 1.69M, compared to an average daily volume of 1.02M.

In the last year, Vericel(VCEL) shares hit a 52-week high of $45.97 and a 52-week low of $28.95.

In the last year, Vericel(VCEL) shares hit a 52-week high of $45.97 and a 52-week low of $28.95.

VCEL News

Simply Wall St 1h
Assessing Vericel Valuation After Winning A US$196.87 Million Government Contract

Advertisement Contract win reframes Vericel’s setup for investors Vericel (VCEL) recently secured a US$196.87 million contract with the Health and Human Servi...

Assessing Vericel Valuation After Winning A US$196.87 Million Government Contract
TipRanks 11h
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 13h
MediWound says Vericel awarded ten-year contract valued at up to $197M

MediWound (MDWD) announced that Vericel (VCEL), its exclusive distributor of NexoBrid in North America, has been awarded a ten-year contract valued at up to $19...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More VCEL News

TipRanks 15h
Vericel awarded Health and Human Services contract valued at $196.87M

Vericel (VCEL) has been awarded a contract by Health and Human Services with a total contract value of $196.87M. This acquisition will allow BARDA to support pr...

Simply Wall St 3d
Exploring Three High Growth Tech Stocks In The US Market

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. I...

Exploring Three High Growth Tech Stocks In The US Market

People also own

Based on the portfolios of people who own VCEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.